 Sara Hashway
Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Whistleblowing | 1 | 2020 | 3 | 0.640 |
Why?
| | Papio anubis | 2 | 2015 | 3 | 0.520 |
Why?
| | Vagina | 2 | 2015 | 203 | 0.430 |
Why?
| | Levonorgestrel | 1 | 2013 | 34 | 0.400 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2013 | 27 | 0.390 |
Why?
| | Contraceptive Agents, Female | 1 | 2013 | 80 | 0.370 |
Why?
| | Microbiota | 2 | 2015 | 730 | 0.300 |
Why?
| | Silver | 2 | 2015 | 36 | 0.220 |
Why?
| | Metal Nanoparticles | 2 | 2015 | 80 | 0.210 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2015 | 507 | 0.130 |
Why?
| | Particle Size | 2 | 2015 | 381 | 0.130 |
Why?
| | Models, Animal | 2 | 2015 | 393 | 0.110 |
Why?
| | Menstruation | 1 | 2015 | 40 | 0.110 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 232 | 0.090 |
Why?
| | Uterus | 1 | 2013 | 227 | 0.090 |
Why?
| | Feces | 1 | 2015 | 495 | 0.090 |
Why?
| | Genomic Imprinting | 1 | 2011 | 27 | 0.090 |
Why?
| | Epistasis, Genetic | 1 | 2011 | 63 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 777 | 0.080 |
Why?
| | Polymerase Chain Reaction | 1 | 2013 | 1041 | 0.080 |
Why?
| | Ultrasonography | 1 | 2013 | 785 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2883 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2011 | 372 | 0.070 |
Why?
| | Gastrointestinal Microbiome | 1 | 2015 | 767 | 0.060 |
Why?
| | Citric Acid | 2 | 2015 | 33 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2011 | 776 | 0.050 |
Why?
| | Insulin Resistance | 1 | 2011 | 1244 | 0.050 |
Why?
| | Animals | 5 | 2015 | 38030 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2015 | 2028 | 0.040 |
Why?
| | Prospective Studies | 1 | 2013 | 8057 | 0.040 |
Why?
| | Povidone | 1 | 2015 | 6 | 0.030 |
Why?
| | Silver Compounds | 1 | 2015 | 5 | 0.030 |
Why?
| | Polyvinyls | 1 | 2015 | 19 | 0.030 |
Why?
| | Toxicity Tests | 1 | 2015 | 53 | 0.030 |
Why?
| | Acetates | 1 | 2015 | 78 | 0.030 |
Why?
| | Ovulation | 1 | 2015 | 46 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2015 | 335 | 0.030 |
Why?
| | Pyrrolidines | 1 | 2015 | 125 | 0.030 |
Why?
| | Organ Size | 1 | 2015 | 461 | 0.030 |
Why?
| | Genome, Bacterial | 1 | 2015 | 123 | 0.030 |
Why?
| | Metagenome | 1 | 2015 | 126 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2015 | 182 | 0.030 |
Why?
| | Administration, Oral | 1 | 2015 | 866 | 0.020 |
Why?
| | Mice | 3 | 2015 | 18329 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2015 | 5983 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1567 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 971 | 0.020 |
Why?
| | Female | 3 | 2015 | 78845 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 396 | 0.020 |
Why?
| | Hyperinsulinism | 1 | 2011 | 114 | 0.020 |
Why?
| | Hepatocytes | 1 | 2011 | 224 | 0.020 |
Why?
| | Adipocytes | 1 | 2011 | 223 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2011 | 337 | 0.020 |
Why?
| | Fatty Liver | 1 | 2011 | 253 | 0.020 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2011 | 265 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 3342 | 0.020 |
Why?
| | Cytokines | 1 | 2011 | 2067 | 0.010 |
Why?
| | Male | 3 | 2015 | 72843 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4560 | 0.010 |
Why?
|
|
Hashway's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|